---
input_text: Managing pregnancy in patients with sickle cell disease from a transfusion
  perspective.Advances in the management of sickle cell disease (SCD) have made it
  possible for most female patients (whether homozygous or compound heterozygous)
  to reach childbearing age and become pregnant. However, even in the less symptomatic
  forms of SCD a high risk of complications during pregnancy and the postpartum period
  can occur for both the mother (1% to 2% mortality) and the fetus. Coordinated care
  from the obstetrician and the sickle cell disease expert is essential, together
  with the active participation of the patient. Vaso-occlusive complications, such
  as vaso-occlusive crisis and acute chest syndrome, often increase in frequency when
  hydroxyurea treatment is interrupted. Obstetric complications, such as pre-eclampsia,
  fetal growth restriction, and preterm delivery, are more common in women with SCD.
  Recent meta-analysis-based studies support prophylactic transfusion. However, there
  have been no randomized trials assessing the benefits of prophylactic transfusion.
  Given the known risk of transfusion complications, including delayed hemolytic transfusion
  reaction and hyperhemolysis, transfusion is not systematically performed in pregnant
  women with SCD. We describe here a case-by-case approach to the management of pregnancy
  in women with SCD based on the medical and transfusion history of each patient.
raw_completion_output: |-
  primary_disease: Sickle cell disease (SCD)

  medical_actions: Prophylactic transfusion; Coordinated care; Case-by-case management approach

  symptoms: Vaso-occlusive crisis; Acute chest syndrome; Pre-eclampsia; Fetal growth restriction; Preterm delivery

  chemicals: Hydroxyurea

  action_annotation_relationships: Prophylactic transfusion PREVENTS complications IN Sickle cell disease (SCD); Coordinated care TREATS complications IN Sickle cell disease (SCD); Case-by-case management approach TREATS complications IN Sickle cell disease (SCD); Hydroxyurea TREATS vaso-occlusive complications IN Sickle cell disease (SCD)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Hydroxyurea TREATS vaso-occlusive complications IN Sickle cell disease (SCD)

  ===

extracted_object:
  primary_disease: MONDO:0007374
  medical_actions:
    - Prophylactic transfusion
    - Coordinated care
    - Case-by-case management approach
  symptoms:
    - Vaso-occlusive crisis
    - Acute chest syndrome
    - HP:0100602
    - HP:0001511
    - HP:0001622
  chemicals:
    - CHEBI:44423
  action_annotation_relationships:
    - subject: Prophylactic transfusion
      predicate: PREVENTS
      object: complications
      qualifier: MONDO:0007374
    - subject: Coordinated care
      predicate: TREATS
      object: complications
      qualifier: MONDO:0007374
    - subject: Case-by-case management approach
      predicate: TREATS
      object: complications
      qualifier: MONDO:0007374
    - subject: Hydroxyurea
      predicate: TREATS
      object: vaso-occlusive complications
      qualifier: MONDO:0007374
      subject_extension: CHEBI:44423
named_entities:
  - id: MONDO:0011382
    label: sickle cell disease
  - id: MONDO:0100096
    label: SARS-CoV-2
  - id: MONDO:0007374
    label: Sickle cell disease (SCD)
  - id: HP:0100602
    label: Preeclampsia
  - id: HP:0001511
    label: Intrauterine growth restriction
  - id: CHEBI:44423
    label: Hydroxyurea (HU)
  - id: CHEBI:35143
    label: Haemoglobin (Hb)
  - id: HP:0001622
    label: Preterm delivery
  - id: CHEBI:50858
    label: corticosteroids
  - id: HP:0032654
    label: Endothelial dysfunction
  - id: HP:0012418
    label: Hypoxia
  - id: HP:0001409
    label: Portal hypertension
  - id: MAXO:0001001
    label: Gene therapies
  - id: MAXO:0000756
    label: Transfusion
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation
  - id: MAXO:0001298
    label: therapy
  - id: MAXO:0009047
    label: Total hip replacement (THR)
  - id: CHEBI:22720
    label: Benzodiazepines
  - id: MONDO:0006079
    label: Acute chest syndrome (ACS)
  - id: CHEBI:24859
    label: Iodine
  - id: MONDO:0005632
    label: Acute chest syndrome
  - id: CHEBI:17334
    label: penicillin
  - id: MAXO:0000118
    label: immunizations
  - id: HP:0001903
    label: anemia
  - id: HP:0001297
    label: stroke
  - id: HP:0012532
    label: Chronic pain
  - id: CHEBI:3216
    label: Buprenorphine
  - id: HP:0001518
    label: Low birth weight
  - id: MAXO:0001006
    label: Full blood count
  - id: MAXO:0000825
    label: Reticulocyte count
  - id: MAXO:0000427
    label: Brain magnetic resonance imaging (MRI)
  - id: HP:0012592
    label: albuminuria
  - id: HP:0100543
    label: cognitive dysfunction
  - id: HP:0000739
    label: anxiety
  - id: HP:0010783
    label: Redness
  - id: CHEBI:33281
    label: antibiotics
  - id: MONDO:0009693
    label: Multiple Myeloma
  - id: CHEBI:145536
    label: Motixafortide
  - id: CHEBI:114786
    label: sodium metabisulfite
  - id: CHEBI:15365
    label: aspirin
  - id: HP:0000093
    label: Proteinuria
  - id: HP:0012622
    label: CKD
  - id: MAXO:0000969
    label: optical coherence tomography (OCT)
  - id: HP:0000505
    label: visual impairment
  - id: CHEBI:28901
    label: busulfan
  - id: CHEBI:82557
    label: treosulfan
  - id: CHEBI:9570
    label: thiotepa
  - id: HP:0100603
    label: Hypertensive disorder of pregnancy (HDP)
  - id: CHEBI:26308
    label: unweighted polygenic risk score (PRS)
  - id: CHEBI:35480
    label: Analgesics
  - id: HP:0012213
    label: Decreased glomerular filtration rate
  - id: HP:0012398
    label: Peripheral oedema
  - id: HP:0001685
    label: Cardiac fibrosis
  - id: MONDO:0005570
    label: hematologic diseases
  - id: HP:0001871
    label: hematologic diseases
  - id: HP:0001712
    label: Left ventricular hypertrophy
  - id: HP:0007760
    label: SCD
  - id: MAXO:0000149
    label: Hematopoietic cell transplant (HCT)
  - id: MAXO:0010203
    label: Echocardiography
  - id: HP:0012531
    label: Pain
  - id: CHEBI:51371
    label: muscle relaxants
  - id: HP:0002140
    label: Arterial ischemic stroke
  - id: MONDO:0019402
    label: Thalassemia major
  - id: MAXO:0000536
    label: Chorionic villus sampling (CVS)
  - id: MONDO:0020380
    label: Sickle cell anemia (SCA)
  - id: MONDO:0005161
    label: Human papillomavirus (HPV) infection
  - id: MAXO:0000759
    label: HPV vaccination
  - id: MAXO:0000447
    label: Surgical removal
  - id: HP:0033138
    label: Right atrial thrombus
  - id: HP:0000989
    label: pruritus
  - id: MAXO:0010041
    label: skin grafting
  - id: MAXO:0000058
    label: Pharmacotherapies
  - id: HP:0001513
    label: obesity
  - id: CHEBI:4027
    label: Cyclophosphamide
  - id: HP:0002617
    label: vasculopathy
  - id: MAXO:0000068
    label: Transplantation
  - id: HP:0004870
    label: chronic hemolytic anemia
  - id: CHEBI:27690
    label: acetazolamide
  - id: CHEBI:22984
    label: Calcium
  - id: MAXO:0001479
    label: allogeneic hematopoietic stem cell transplantation
  - id: CHEBI:18050
    label: L-glutamine
  - id: MAXO:0001175
    label: liver transplantation
  - id: HP:0000952
    label: jaundice
  - id: HP:0025637
    label: vasospasm
  - id: CHEBI:125354
    label: plerixafor
  - id: MAXO:0001017
    label: Vaccination
